Swissmedic
REGULATORY UPDATE
Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances
Published: 10/1/2026Detected: 10/1/2026
Summary preview
Adaptations required for issuing establishment licences and GMP certificates for manufacturers of active substances, indicating that regulatory expectations for how active substance manufacturers are assessed and…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
#SwissMedic
#establishment licence
#GMP certificate
#active substances
#API manufacturer
Official Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026
- Revision of the Guidance document Authorisation Biosimilar10/1/2026
- Swissmedic Portal Release – New Features Available from 23 September 20269/24/2026
- I-SMI.TI.22e Notifications according to Article 41, MPLO9/23/2026
- ElViS 2.09/4/2026